Can NLR, PLR, and LMR be used as prognostic indicators in patients with pulmonary embolism? Author's reply on commentary COMMENT
Yükleniyor...
Dosyalar
Tarih
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
Assoc Basic Medical Sci Federation Bosnia & Herzegovina Sarajevo
Erişim Hakkı
info:eu-repo/semantics/openAccess
Attribution 3.0 United States
Attribution 3.0 United States
Özet
We appreciate the comments made by Dr. Bedel et al. NLR, PLR, and LMR are affected by various diseases such as oncological, collagen tissue, inflammatory, or severe renal/liver diseases [1]. Due to this, we have listed some of the dis-orders mentioned above in the tables. Hematological diseases, collagen tissue disease, inflammatory diseases, congenital heart disease, or severe renal/liver disease were excluded from the study. However, the presence of malignancy did not affect our results in the regression analysis.
Açıklama
Yıldırım, Tarık (Balikesir Author)
Anahtar Kelimeler
Research & Experimental Medicine
Kaynak
Bosnian Journal of Basic Medical Sciences
WoS Q Değeri
Scopus Q Değeri
Cilt
21
Sayı
4
Künye
Onay
İnceleme
Ekleyen
Referans Veren
Creative Commons lisansı
Aksi belirtilmedikçe, bu öğenin lisansı şu şekilde tanımlanmıştır info:eu-repo/semantics/openAccess













